Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3072490 | 0.82 | SLC1A3 (0.41) | RCE1KMT2AHTTMAPTSLC1A3 | |
| SCHEMBL10566320 | 0.82 | SLC1A3 (0.41) | RCE1KMT2AHTTMAPTSLC1A3 | |
| SCHEMBL19993652 | 0.82 | SLC1A3 (0.41) | RCE1KMT2AHTTMAPTSLC1A3 | |
| SCHEMBL4413012 | 0.82 | SLC6A2 (0.45) | RCE1KMT2AHTTSLC6A2SLC6A4 | |
| SCHEMBL19546244 | 0.78 | SCN1A (0.36) | HTTSLC6A2SLC6A4SLC6A3MAPT | |
| SCHEMBL227684 | 0.77 | TSHR (0.48) | KMT2ASLC6A2SLC6A4SLC6A3SLC1A3 | |
| SCHEMBL6578270 | 0.76 | CYP1A2 (0.51) | KMT2AHTTMAPTMEN1CYP1A2 | |
| SCHEMBL19043237 | 0.76 | TSHR (0.45) | KMT2ATACR1MAPTSLC1A3SLC1A2 | |
| SCHEMBL4537628 | 0.76 | CA1 (0.51) | KMT2AHTTTACR1SLC1A3SLC1A2 | |
| SCHEMBL8904530 | 0.76 | CA1 (0.51) | KMT2AHTTTACR1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1942861-A2 | MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION | The Procter and Gamble Company (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | PROCTER & GAMBLE COMPANY, THE | 2007-06-14 | — | — | US | disclosed |
| WO-2007052224-A2 | MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | CUTA, PARG, POLG | RCE1 2938/4885KMT2A 4539/4885HTT 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.